Under the partnership, Ambry will incorporate RainDance's RDT 1000 platform into sequence enrichment and targeted resequencing applications.
Ambry will offer services for sequence enrichment and resequencing validation using RainDance Technologies' RDT 1000 system.
Ambry said the chip offers a "higher-resolution approach" to standard karyotyping for stem cells, as well as increased coverage in known stem cell- and cancer-associated genes compared to Agilent's standard 44K CGH array.
Ambry Genetics and ImaGenes are partnering with SoftGenetics and CLC Bio, respectively, to provide more in-depth bioinformatics services for their customers.
The strategic alliance gives Ambry's sequencing customers use of the NextGENe analysis software.
Athena alleges that Ambry's sale of tests for certain types of diabetes infringes on patents that Athena licensed from its development partner Correlagen.
Ambry was certified to use the SureSelect target enrichment technology for next-gen sequencing services.
Genedata, Ambry Genetics, Arrayit, NanoInk
The company passed certification for using Agilent's arrays for genomics researchers.
The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.
In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.
MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.
In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.